Sema4

Sema4

Sema4

Sema4 is a patientcentered health intelligence company, dedicated to transforming healthcare through datadriven insights.
Founded
2017
Raised
$121M
Follow us
Featured on
Alexa global traffic share
Latest funding
$121,000,000
Venture capital (Series C) - 2020
BlackRock Oak HC/FT Deerfield +5
Team Size
1–10
Employees
Pulse 2.0

Sema4 (SMFR) Stock: Why It Fell Over 19% Today

Pulse 2.0

Sema4 Holdings (SMFR) Stock: $3.50 Target And Buy Rating

MedCity News

Sema4 to acquire GeneDx, capturing $200M in private investment

Pulse 2.0

Sema4 Stock (SMFR): Why The Price Jumped

neurons.AI

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of …

neurons.AI

Sema4 to Participate in Upcoming Investor Conferences

neurons.AI

Sema4 to Participate in Upcoming Investor Conferences

$121,000,000 Venture capital (Series C)
FinSMEs , Pulse 2.0

Sema4 Closes $121M Series C Funding; Post-Money Valued at $1 Billion

TechCrunch

Using population health analysis to improve patient care brings Sema4 a $1.1 billion valuation

Xconomy

With New Test, Schadt’s Sema4 Aims to Broaden Scope of Newborn Screening

Health
Xconomy

Sema4, Eric Schadt’s Genomics Startup, Spins Out of Sinai to Raise Cash

Health